New product: Jyseleca (filgotinib) 100 mg and 200mg film-coated tablets

This is licensed for the treatment of moderate to severe active rheumatoid arthritis in adults who have responded inadequately to, or who are intolerant to one or more DMARDs. It may be used as monotherapy or in combination with methotrexate.

electronic Medicines compendium